BioSpace News Archive

Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, added two new leaders to its management team to oversee regulatory, policy, and reimbursement activities as the company advances its products toward commercialization.

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), today announced that its wholly owned subsidiary, PRO-DIP, LLC (“PRO-DIP”), was issued U.S. Patent No. 11,273,965 by the U.S. Patent and Trademark Office on March 15, 2022.

Open Book Extracts, a cGMP-certified manufacturer and distributor of the industry’s most innovative and highest quality cannabinoid ingredients and finished products, announced the completion of its first randomized, controlled trial on rare cannabinoids, with the support of Radicle Science, a transformative healthtech B-corp validating health and wellness products for the first time.

Neogen Corporation (NASDAQ: NEOG) announced today the results of the third quarter of its 2022 fiscal year, which ended February 28.

Stereotaxis announces that Poland’s National Institute of Cardiology, the leading clinical center of cardiology and cardiac surgery in Warsaw, has established the first robotic electrophysiology program in the country with Stereotaxis’ Genesis Robotic Magnetic Navigation system.

Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the publication of results from EVoluSIon (EVSI), a large, prospective, multi-center study of clinical outcomes following minimally invasive sacroiliac joint (SIJ) fusion with decortication.

Precision Optics Corporation, Inc. (OTCQB: PEYE), today announced the receipt of multiple production orders totaling approximately $2.5 million from a large medical device company to meet increased demand for the customer’s spinal surgery product that utilizes Precision Optics proprietary illumination technology.

Sun Pharmaceutical Industries Inc., USA (Sun Pharma) today announced that five data abstracts for ILUMYA will be presented at the 2022 American Academy of Dermatology (AAD) Annual Meeting, taking place March 25-29.

MedPacto announced on March 24th that it has recently appointed global clinical expert and former lead clinician at KaryoPharm, Dr. Timothy R. Allen as the EVP of Clinical Development at MedPacto Therapeutics, a U.S. corporation.

GenXys Health Care Systems, Inc., the global leader in precision prescribing software and embedded pharmacogenetic data, today joins the American Society of Pharmacovigilance in raising awareness of adverse drug reactions (ADRs) on National Adverse Drug Event Awareness Day.